Clinics in Dermatology
Volume 24, Issue 6 , Pages 521-533 , November 2006

Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue

  • Alan J. Hakim, MA

      Affiliations

    • Department of Rheumatology, Whipps Cross University Hospital, Leytonstone, E11 1NR London, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 02085356723; fax: +44 02085356504
    • ,
  • Anshoo Sahota, MB

      Affiliations

    • Department of Dermatology, Whipps Cross University Hospital, Leytonstone, E11 1NR London, UK

References 

  1. Al-Rawi ZS, Al-Aszawi AJ, Al-Chalabi T. Joint mobility among university students in Iraq. Br J Rheumatol. 1985;24:326–331
  2. Larsson LG, Baum J, Mudholkar GS, Srivastava DK. Hypermobility: prevalence and features in a Swedish population. Br J Rheumatol. 1993;32:116–119
  3. Birrell FN, Adebajo AO, Hazleman BL, Silman AJ. High prevalence of joint laxity in West Africans. Br J Rheumatol. 1994;33:56–59
  4. Didia BC, Dapper DV, Boboye SB. Joint hypermobility syndrome among undergraduate students. East Afr Med J. 2002;79:80–81
  5. Verd Vallespir S, Mas de Salva J, Arboleda Gonzalez L. Joint hypermobility in Palma school children. An Esp Pediatr. 1991;35:17–20
  6. Gedalia A, Press J, Klein M, Buskila D. Joint hypermobility and fibromyalgia in school children. Ann Rheum Dis. 1993;52:494–496
  7. Forleo LHA, Hilario MOE, Peixoto AL, Naspitz CK, Goldenberg J. Articular hypermobility in school children in Sao Paulo, Brazil. J Rheumatol. 1994;20:916
  8. Rikken-Bultman DG, Wellink L, van Dongen PW. Hypermobility in two Dutch school populations. Eur J Obstet Gynecol Reprod Biol. 1997;73:182–192
  9. El-Garf AK, Mahmoud GA, Mahgoub EH. Hypermobility among Egyptian children: prevalence and features. J Rheumatol. 1998;25:1003–1005
  10. Qvindesland A, Jonsson H. Articular hypermobility in Icelandic 12-year-olds. Rheumatology (Oxford). 1999;38:1014–1016
  11. Duro JC, Vega E. Prevalence of articular hypermobility in school children: a one district study in Barcelona. Rheumatology (Oxford). 2000;39:1153
  12. Klemp P, Williams SM, Stansfield SA. Articular mobility in Maori and European New Zealanders. Rheumatology (Oxford). 2002;41:554–557
  13. Hakim AJ, Cherkas LF, Grahame R, Spector T, MacGregor AJ. The genetic epidemiology of joint hypermobility: a female twin population study. Arthritis Rheum. 2004;50:2640–2646
  14. Grahame R, Jenkins JM. Joint hypermobility—asset or liability? A study of joint mobility in ballet dancers. Ann Rheum Dis. 1972;31:109–111
  15. Mc Cormack M, Briggs J, Hakim AJ, Grahame R. A study of joint laxity and the impact of the benign joint hypermobility syndrome in student and professional ballet dancers. J Rheumatol. 2004;31:173–178
  16. Larsson LG, Baum J, Mudholkar GS, Kollia GD. Benefits and disadvantages of joint hypermobility among musicians. N Engl J Med. 1993;329:1079–1082
  17. Decoster LC, Vailas JC, Lindsay RH, Williams GR. Prevalence and features of joint hypermobility among adolescent athletes. Arch Pediatr Adolesc Med. 1997;151:989–992
  18. Beighton PH, Solomon L, Soskolne CL. Articular mobility in an African population. Ann Rheum Dis. 1973;32:413–417
  19. Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract. 2003;57:163–166
  20. Beighton P, De Paepe A, Steinmann B, et al. Ehlers Danlos syndromes: revised nosology, Villefranche 1997. Ehlers Danlos National Foundation (USA) and Ehlers Danlos Support Group (UK). Am J Med Genet. 1998;77:31–37
  21. Grahame R, Bird HA, Dolan AL, et al. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome. J Rheumatol. 2000;27:1777–1779
  22. Grahame R. Joint hypermobility and genetic collagen disorders. Are they related?. Arch Dis Child. 1999;80:188–191
  23. Grahame R, Pyeritz RE. The Marfan syndrome: joint and skin manifestations are prevalent and correlated. Br J Rheumatol. 1995;34:126–131
  24. Stickler GB, Belau PG, Farrell FJ, et al. Hereditary progressive arthroopthalmopathy. Mayo Clin Proc. 1965;40:433–455
  25. De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Gen. 1996;62:417–426
  26. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160–172
  27. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. The international chronic fatigue study group. Ann Intern Med. 1994;121:953–959
  28. Goldman JA. Hypermobility and deconditioning: important links to fibromyalgia/fibrositis. South Med J. 1991;84:1192–1196
  29. Acasuso-Diaz M, Collantes-Estevez E. Joint hypermobility in patients with fibromyalgia syndrome. Arthritis Care Res. 1998;11:39–42
  30. Karaaslan Y, Haznedaroglu S, Ozturk M. Joint hypermobility and primary fibromyalgia: a clinical enigma. J Rheumatol. 2000;27:1774–1776
  31. Fitzcharles MA. Is hypermobility a factor in fibromyalgia?. J Rheumatol. 2000;27:1587–1589
  32. Ofluoglu D, Gunduz OH, Kul-Panza E, Guven Z. Hypermobility in women with fibromyalgia syndrome. Clin Rheumatol. 2006;5:291–293
  33. Barron DF, Cohen BA, Geraghty MT, Violand R, Rowe PC. Joint hypermobility is more common children with chronic fatigue syndrome than in healthy controls. J Pediatr. 2002;141:421–425
  34. Nijs J, Aerts A, De Meirleir K. Generalized joint hypermobility is more common in chronic fatigue syndrome than in healthy control subjects. J Manipulative Physiol Ther. 2006;29:32–39
  35. Hakim AJ, Ashton S. Undiagnosed, joint hypermobility syndrome patients have poorer outcome than peers following chronic back pain rehabilitation. Rheumatology. 2005;44(3 Suppl 1):255;[Abstract]
  36. Hakim AJ, Grahame R. Joint hypermobility. Best Pract Res Clin Rheumatol. 2003;17:989–1004[Review 52 refs]
  37. Keer R, Edwards-Fowler A, Mansi E. Management of the hypermobile adult. In:  Kerr R,  Grahame R editor. In hypermobility syndrome; recognition and management for physiotherapists. London: Butterworth Heineman; 2003;p. 87–106
  38. Ferrell WR, Tennant N, Sturrock RD, et al. Amelioration of symptoms by enhancement of proprioception in patients with joint hypermobility syndrome. Arthritis Rheum. 2004;50:3323–3328
  39. Mallik AK, Ferrell WR, McDonald AG, Sturrock RD. Impaired proprioceptive acuity at the proximal interphalangeal joint in patients with the hypermobility syndrome. Br J Rheumatol. 1994;33:631–637
  40. Hall MG, Ferrell WR, Sturrock RD, et al. The affect of the hypermobility syndrome on knee joint proprioception. Br J Rheumatol. 1995;34:121–125
  41. Lumley M, Jordan M, Rubenstein R, et al. Psychosocial functioning in the Ehlers Danlos Syndrome. Am J Med Genet. 1994;53:149–152
  42. Bulbena A, Duro JC, Porta M, et al. Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res. 1993;46:59–68
  43. Martin-Santos R, Bulbena A, Portaet M, et al. Association between joint hypermobility syndrome and panic disorder. Am J Psychiatry. 1998;155:1578–1583
  44. Arendt-Nielsen L, Kaalund S, Bjerring P, Hogsaa D. Insufficient effect of local analgesics in Ehlers Danlos type III patients. Acta Anaesthesiol Scand. 1990;34:358–361
  45. Arendt-Nielsen L, Kaalund S, Hogsaa D, Bjerring P. The response of local anaesthetics (EMLA cream) as a clinical test to diagnose between hypermobility and Ehlers Danlos III Syndrome. Scand J Rheumatol. 1991;20:190–195
  46. Hakim AJ, Norris P, Hopper C, Grahame R. Local anaesthetic failure; does joint hypermobility provide the answer?. J R Soc Med. 2005;98:84–85
  47. Westling L, Mattiasson A. General joint hypermobility and temporomandibular joint derangement in adolescents. Ann Rheum Dis. 1992;51:87–90
  48. Dijkstra PU, de Bont LG, de Leeuw R, Stegenga B, Boering G. Temporomandibular joint osteoarthritis and temporomandibular joint hypermobility. Cranio. 1993;11:268–275
  49. Dijkstra PU, de Bont LG, Stegenga B, Boering G. Temporomandibular joint osteoarthritis and generalized joint hypermobility. Cranio. 1992;10:221–227
  50. Conti PC, Miranda JE, Araujo CR. Relationship between systematic joint laxity, TMJ hypertranslation, and intra-articular disorders. Cranio. 2000;18:192–197
  51. Kavuncu V, Sahin S, Kamanli A, et al. The role of systemic hypermobility and condylar hypermobility in temporomandibular joint dysfunction syndrome. Rheumatol Int. 2006;26:257–260
  52. Bird HA, Tribe CR, Bacon PA. Joint hypermobility leading to osteoarthritis and chondrocalcinosis. Ann Rheum Dis. 1978;37:203–211
  53. Jonsson H, Valtysdottir ST. Hypermobility features in patients with hand osteoarthritis. Osteoarthritis Cartilage. 1995;3:1–5
  54. Al-Rawi Z, Nessan AH. Joint hypermobility in patients with chondromalacia patellae. Br J Rheumatol. 1997;36:1324–1327
  55. Dolan AL, Hart DJ, Doyle DV, Grahame R, Spector TD. The relationship of joint hypermobility, bone mineral density, and osteoarthritis in the general population: the Chingford Study. J Rheumatol. 2003;30:799–803
  56. Kraus VB, Li YJ, Martin ER, et al. Articular hypermobility is a protective factor for hand osteoarthritis. Arthritis Rheum. 2004;50:2178–2183
  57. Byers PH. Osteogenesis imperfecta. In:  Royce PLSB editors. Connective tissue and its inheritable disorders. New York: Wiley-Liss; 1993;p. 317–350
  58. Dolan AL, Arden NK, Grahame R, Spector TD. Assessment of bone density in Ehlers Danlos Syndrome by ultrasound and densitometry. Ann Rheum Dis. 1998;57:630–633
  59. Carter N, Duncan E, Wordsworth P. Bone mineral density in adults with Marfan syndrome. Rheumatology (Oxford). 2000;39:307–309
  60. Nijs J, Van Essche E, De Munck M, Dequeker J. Ultrasound, axial, and peripheral measurements in female patients with benign hypermobility syndrome. Calcif Tissue Int. 2000;67:37–40
  61. Gulbahar S, Sahin E, Baydar M, et al. Hypermobility syndrome increases the risk for low bone mass. Clin Rheumatol. 2006;25:511–514
  62. Dolan AL, Mishra MB, Chambers JB, Grahame R. Clinical and echocardiographic survey of the Ehlers Danlos syndrome. Br J Rheumatol. 1997;36:459–462
  63. Ahmad N, Richards AJ, Murfett HC, et al. Prevalence of mitral valve prolapse in Stickler syndrome. Am J Med Genet. 2003;116A:234–237
  64. Hakim AJ, Grahame R. Non-musculoskeletal symptoms in Joint Hypermobility Syndrome: indirect evidence for autonomic dysfunction. Rheumatology. 2004;43:1194–1195
  65. Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med. 2003;115:33–40
  66. Rowe PC, Barron DF, Calkins H, et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers Danlos syndrome. J Pediatr. 1999;135:494–499
  67. Al-Rawi ZS, Al-Rawi ZT. Joint hypermobility in women with genital prolapse. Lancet. 1982;1:1439–1441
  68. Norton PA, Baker JE, Sharp HC, Warenski JC. Genitourinary prolapse and joint hypermobility in women. Obstet Gynecol. 1995;85:225–228
  69. Bai SW, Choe BH, Kim JY, Park KH. Pelvic organ prolapse and connective tissue abnormalities in Korean women. J Reprod Med. 2002;47:231–234
  70. Mc Intosh LJ, Stanitski DF, Mallett VT, Frahm JD, Richardson DA, Evans MI. Ehlers Danlos Syndrome: relationship between joint hypermobility, urinary incontinence, and pelvic floor prolapse. Gynecol Obstet Invest. 1996;41:135–139
  71. Marshman D, Percy J, Fielding I, Delbridge I. Rectal prolapse: relationship with joint mobility. Aust N Z J Surg. 1987;57:827–829
  72. van Dongen PW, de Boer M, Lemmens WA, Theron GB. Hypermobility and peripartum pelvic pain syndrome in pregnant South African women. Eur J Obstet Gynecol Reprod Biol. 1999;84:77–82
  73. Barabas AP. Ehlers Danlos Syndrome: associated with prematurity and premature rupture of foetal membranes; possible increase in incidence. Br Med J. 1966;5515:682–684
  74. Thornton JG, Hill J, Bird HA. Complications of pregnancy and benign joint hyperlaxity. Ann Rheum Dis. 1988;47:228–231
  75. Brear SG, Beton D, Slaven Y, Honeybourne D. Spontaneous pneumothoraces are associated with mitral valve prolapse. Arthritis Rheum. 1984;39:219
  76. Morgan AW, Pearson S, Bird H. Respiratory symptoms in Ehlers Danlos Syndrome and the benign joint hypermobility syndrome. Arthritis Rheum. 1996;39:S136
  77. Rose PS, Levy HP, Liberfarb RM, et al. Stickler syndrome: clinical characteristics and diagnostic criteria. Am J Med Genet. 2005;138:199–207
  78. Stickler GB, Hughes W, Houchin P. Clinical features of hereditary arthroophthalmopathy (Stickler Syndrome): a survey. Genet Med. 2001;3:192–196
  79. Pope FM, Burrows NP. Ehlers Danlos Syndrome has varied molecular mechanisms. J Med Genet. 1997;34:400–410
  80. Loughlin J, Irvin C, Hardwick LJ, et al. Linkage of the gene that encodes the alpha-1 chain of type V collagen to type II Ehlers Danlos Syndrome. Hum Mol Genet. 1995;4:1649–1651
  81. Wenstrup RJ, Langland GT, Willing MC, D'Souza VN, Cole WG. A splice-junction mutation in the region of COL5A1 that encodes for the carboxyl propeptide of pro alpha-1 (V) chains result in the gravis form of the Ehlers Danlos Syndrome (type I). Hum Mol Genet. 1996;5:1733–1736
  82. Burrows NP, Nicholls AC, Yates JR, et al. The gene encoding collagen alpha-1 (V)(COL5A1) is linked to mixed Ehlers Danlos Syndrome type I/II. J Invest Dermatol. 1996;106:1273–1276
  83. De Paepe A, Nuytinck L, Hausser I, Anton-Lamprecht I, Naeyaert JM. Mutations in the COL5A1 gene are causal in the Ehlers Danlos Syndromes I and II. Am J Hum Genet. 1997;60:547–554
  84. Michalickova K, Susic M, Willing MC, Wenstrup RJ, Cole WG. Mutations of the alpha-2 (V) chain of type V collagen impair matrix assembly and produce Ehlers Danlos Syndrome type I. Hum Mol Genet. 1998;7:249–255
  85. Lichtenstein JR, Martin GR, Kohn LD, Byers PH, McKusick VA. Defect of conversion of procollagen to collagen in a form of Ehlers Danlos Syndrome. Science. 1973;182:298–299
  86. Eyre DR, Shapiro FD, Aldridge JF. A heterogeneous collagen defect in a variant of the Ehlers Danlos Syndrome type VII. J Biol Chem. 1985;260:11322–11329
  87. Byers PH, Duvic M, Atkinson M, et al. Ehlers Danlos Syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type 1 collagen. Am J Med Genet. 1997;72:94–105
  88. Malfait F, Hakim AJ, De Paepe A, Grahame R. The genetics of joint hypermobility syndrome. Rheumatology. 2006;45:502–507
  89. Zweers M, Hakim AJ, Grahame R, Schalkwijk J. Tenascin-X deficiency and haploinsufficiency as a cause of generalized joint hypermobility. Arthritis Rheum. 2004;50:2742–2749
  90. Mercuri E, Lampe A, Straub V, et al. Congenital muscular dystrophy with short stature, proximal contractures and distal laxity. Neuropediatrics. 2004;35:224–229
  91. Camacho Vanegas O, Bertini E, Zhang RZ, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci U S A. 2001;98:7516–7521
  92. Pan TC, Zhang RZ, Sudano DG, et al. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet. 2003;73:355–369
  93. Baker NL, Morgelin M, Peat R, et al. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet. 2005;14:279–293
  94. Sykes B, Ogilvie D, Wordsworth P, Anderson Jones N. Osteogenesis imperfecta is linked to both type I collagen structural genes. Lancet. 1986;12:69–72
  95. Francomano CA, Liberfarb RM, Hirose T, et al. The Stickler syndrome is closely linked to COL2A1, the structural gene for type II collagen. Pathol Immunopathol. 1988;7:104–106
  96. Ahmad NN, Ala-kokko L, Knowlton RG, et al. Stop codon in the procollagen gene II in a family with the Stickler syndrome. Proc Natl Acad Sci U S A. 1991;88:6624–6627
  97. Brunner HG, van Beersum SEC, Warman ML, et al. A Stickler Syndrome gene is linked to chromosome 6 near COL11A2 gene. Hum Mol Genet. 1994;3:1561–1564
  98. Sirko-Osadsa DA, Murray MA, Scott JA, et al. Stickler syndrome without eye involvement is caused by mutations in COL11A2, the gene encoding the alpha2(XI) chain of type XI collagen. J Pediatr. 1998;132:368–371
  99. Lee B, Godfrey M, Vitale E, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 1991;352:330–334
  100. Kainulainen K, Karttunen L, Puhakka L, Sakai L, Peltonen L. Mutations in the fibrillin gene responsible for dominant ectpopia lentis and neonatal Marfan syndrome. Nat Genet. 1994;6:64–69
  101. Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin-1 in the Marfan syndrome and related disorders. Hum Mol Genet. 1995;4:1799–1809
  102. Zhang H, Apfelroth SD, Hu W, et al. Structure and expression of fibrillin-2, a novel microfibrillar component located in elastic matrices. J Cell Biol. 1994;124:855–863

PII: S0738-081X(06)00106-4

doi: 10.1016/j.clindermatol.2006.07.013

Clinics in Dermatology
Volume 24, Issue 6 , Pages 521-533 , November 2006

Article Tools

* Image Usage & Resolution